Figure 6.
1V270-micelles are tolerated by non-human primates. Escalating doses of 1V270-micelles were infused intravenously to cynomolgus monkeys every fourteenth day. Doses of 0.01, 0.03, 0.1, 0.3, 0.9, and 2.7 mg/kg 1V270-micelles were administered (n = 3). Blood samples were taken at indicates times after each infusion. (A) Dosing and sampling schedule. (B) CRP levels in blood. (C) Plasma cytokine levels. (D) Plasma level of 1V270. Vertical black dotted lines indicate infusion of 1V270-micelles.

1V270-micelles are tolerated by non-human primates. Escalating doses of 1V270-micelles were infused intravenously to cynomolgus monkeys every fourteenth day. Doses of 0.01, 0.03, 0.1, 0.3, 0.9, and 2.7 mg/kg 1V270-micelles were administered (n = 3). Blood samples were taken at indicates times after each infusion. (A) Dosing and sampling schedule. (B) CRP levels in blood. (C) Plasma cytokine levels. (D) Plasma level of 1V270. Vertical black dotted lines indicate infusion of 1V270-micelles.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close